Sign in →

Test Code RPDE Rapidly Progressive Dementia Evaluation, Spinal Fluid


Ordering Guidance


In individuals with a high clinical suspicion of Alzheimer disease, order ADEVL / Alzheimer Disease Evaluation, Spinal Fluid.

 

This test can only be performed on specimens collected and transported in polypropylene tubes. If this test is ordered and a polystyrene tube is received, it will be canceled and automatically reordered by the laboratory as CJDE / Creutzfeldt-Jakob Disease Evaluation, Spinal Fluid.

 

For cases where there is high suspicion of human prion disease supported by clinical or paraclinical magnetic resonance imaging features, order CJDE / Creutzfeldt-Jakob Disease Evaluation, Spinal Fluid.

Early in the disease course, or in atypical cases, the disease progression may be slower and include significant clinical overlap (dementia, rigidity, myoclonus) with other potential causes of rapidly progressive dementia, including Alzheimer disease. In the latter case, it would be more appropriate to order this test.



Specimen Required


Supplies: CJD/RPD Evaluation Kit (T966)

Container/Tube:

Preferred: 2 Sarstedt CSF False Bottom Tubes 63.614.625 (2.5 mL)

Acceptable: Sarstedt 72.703.600 (1.5 mL) or Sarstedt 72.694.600 (2 mL)

Specimen Volume: 2 tubes; each containing 1.5 to 2.5 mL

Collection Instructions:

1. Perform lumbar puncture and discard the first 1 to 2 mL of cerebrospinal fluid (CSF).

2. Collect two tubes of CSF directly into an acceptable collection tube until the tube is at least 50% full.

3. Send CSF specimen in original collection tube. Do not aliquot.

Note: Polystyrene collection tubes are not acceptable. Exposure of CSF to polystyrene tubes may result in falsely low Abeta42 concentrations.

The Alzheimer's Association consensus protocol for handling of CSF for clinical measurements of Abeta42 and tau recommends using the drip method for CSF collection and directly collecting into a low-bind polypropylene tube. Although some clinicians prefer the syringe pull method due to speed of collection, the drip method reduces the risk of Abeta42 binding to the plastic of any syringe used.

4. Collection instructions can also be found on Spinal Fluid Specimen Collection Instructions for Creutzfeldt-Jakob Disease and Rapidly Progressive Dementia Evaluations (T974).


Secondary ID

620376

Profile Information

Test ID Reporting Name Available Separately Always Performed
RPDEI RPD Eval Interp, CSF No Yes
RTQPC RT-QuIC Prion, CSF No Yes
TTPTQ t-Tau/p-Tau No Yes
ADRTQ Alzheimer's Disease Evaluation, CSF No Yes

Method Name

RPDEI: Medical Interpretation

RTQPC: Real-Time Quaking-Induced Conversion (RT-QuIC)

TTPTQ: Calculation

ADRTQ: Electrochemiluminescent Immunoassay (ECLIA)

Specimen Type

CSF

Specimen Minimum Volume

See Specimen Required

Specimen Stability Information

Specimen Type Temperature Time Special Container
CSF Frozen (preferred) 28 days BlueTop SARSTEDT
  Refrigerated  14 days BlueTop SARSTEDT
  Ambient  12 hours BlueTop SARSTEDT

Reject Due To

Gross hemolysis Reject
Gross lipemia Reject
Gross icterus Reject
Discolored CSF Reject

Reference Values

RT-QuIC PRION, CSF:

Negative

 

t-TAU/p-TAU:

≤18

 

p-TAU/ABETA 42:

≤0.028

 

BETA-AMYLOID (1-42) (Abeta42):

>834 pg/mL

 

TOTAL TAU:

≤238 pg/mL (Alzheimer disease)

≤393 pg/mL (Creutzfeldt-Jakob disease)

 

PHOSPHORYLATED TAU 181:

≤21.6 pg/mL

Day(s) Performed

Monday through Friday, Sunday

Report Available

3 to 8 days

Performing Laboratory

Mayo Clinic Laboratories in Rochester

CPT Code Information

84999

83520 x 3